Avid Bioservices Inc
NASDAQ:CDMO
Avid Bioservices Inc
Revenue
Avid Bioservices Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Avid Bioservices Inc
NASDAQ:CDMO
|
Revenue
$140.9m
|
CAGR 3-Years
25%
|
CAGR 5-Years
31%
|
CAGR 10-Years
20%
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
Avid Bioservices Inc
Revenue Breakdown
Breakdown by Geography
Avid Bioservices Inc
Breakdown by Segments
Avid Bioservices Inc
Total Revenue:
149.3m
USD
|
Manufacturing Revenue:
125.4m
USD
|
Process Development Revenue:
23.9m
USD
|
See Also
What is Avid Bioservices Inc's Revenue?
Revenue
140.9m
USD
Based on the financial report for Oct 31, 2023, Avid Bioservices Inc's Revenue amounts to 140.9m USD.
What is Avid Bioservices Inc's Revenue growth rate?
Revenue CAGR 10Y
20%
Over the last year, the Revenue growth was 5%. The average annual Revenue growth rates for Avid Bioservices Inc have been 25% over the past three years , 31% over the past five years , and 20% over the past ten years .